Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in ra...
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats
About this item
Full title
Author / Creator
Publisher
Netherlands: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
This study investigated the effects of the receptor activator for nuclear factor kappaB ligand (RANKL) inhibitor, osteoprotegerin (OPG), on tumor-induced allodynia, osteolysis, and bone histology in the mammary tumor (MRMT-1) rat model for bone cancer pain.
Rats (n = 8/group) were inoculated with MRMT-1 or culture medium in the proximal right ti...
Alternative Titles
Full title
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68113425
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68113425
Other Identifiers
ISSN
0262-0898
E-ISSN
1573-7276
DOI
10.1007/s10585-006-9026-x
